ONCOCARE - Innovative AI SaaS solution for efficient management and delivery of oncology therapies

Project facts

Project promoter:
SYNAPTIQ TECHNOLOGIES SRL(RO)
Project Number:
RO-INNOVATION-0057
Status:
In implementation
Initial project cost:
€261,275
Donor Project Partners:
International Development Norway IDN(NO)

Description

Synaptiq Technologies is based in Cluj-Napoca, Romania and was created in 2021. They specialize in software development for the MedTech business utilizing artificial intelligence.  The company''s core business is developing, and marketing tumor delineation software based on well-done research in this area to radiology centers. Conducting research, software development, and product management are the major tasks.

The main objective of the project is to develop an innovative artificial intelligence SaaS solution for efficient management and delivery of radiotherapy to oncology patients. The background of this solution is due to the scarcity of radiologists on the market which is also amplified by the fact that contouring medical pictures takes a long time. The project solution will help radiologists see more patients by cutting the time it takes them to outline medical pictures of patients from several hours to a few minutes. The ambition is that the project will lead to more patients getting the treatment they need. The project is implemented in partnership with International Development Norway (IDN). IDN will provide technical and user assistance to Synaptiq Technologies during the product development process. IDN will perform various other tasks like set up the technical requirements, collect testing data and analyze and design a feasible business model for the Norwegian market. The partnership will also enable Synaptiq Technologies to make an international relationship and expand more efficiently.

The extended project aim is to improve the efficiency of radiotherapy treatment planning, reduce the burden on medical staff, increase patient accessibility to treatment, and ultimately contribute to a quicker and more effective cancer treatment process. The project aims to automate and streamline the contouring of organs-at-risk, making the software a central solution for radiotherapy planning with a vision for same-day treatment planning in the future.

Information on the projects funded by the EEA and Norway Grants is provided by the Programme and Fund Operators in the Beneficiary States, who are responsible for the completeness and accuracy of this information.